Fund Holdings — Kynam Capital Management, LP

Total Portfolio Value
$955.19M
Total Bought
$191.00M
Total Sold
$34.57M
Net Transaction
+$156.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
NATERA INC(NTRA)2,000,0002,014,408+14,408182,920218,14022.84%+35,220
DYNAVAX TECHNOLOGIES CORP4,239,7807,082,562+2,842,78252,61679,5378.33%+26,922
BIOCRYST PHARMACEUTICALS INC(BCRX)6,527,4918,826,710+2,299,21933,16054,5495.71%+21,389
COGENT BIOSCIENCES INC(COGT)8,500,0009,260,385+760,38557,12078,0658.17%+20,945
VIRIDIAN THERAPEUTICS INC(VRDN)133,8771,750,000+1,616,1232,34422,7682.38%+20,423
BURNING ROCK BIOTECH LTD(BNR)0974,668+974,66806,2840.66%+6,284
VAXCYTE INC(PCVX)745,000753,240+8,24050,89156,8775.95%+5,986
CELLDEX THERAPEUTICS INC NEW(CLDX)2,900,0003,388,967+488,967121,713125,42613.13%+3,713
CG ONCOLOGY INC(CGON)053,911+53,91101,7020.18%+1,702
TRAVERE THERAPEUTICS INC(TVTX)2,000,0002,021,659+21,65915,42016,6181.74%+1,198
ACELYRIN INC396,379831,310+434,9312,6763,6660.38%+991
TYRA BIOSCIENCES INC(TYRA)515,190566,715+51,5258,4499,0620.95%+613
AMARIN CORP PLC12,022,95712,155,830+132,87310,7108,3630.88%-2,347
CARIBOU BIOSCIENCES INC(CRBU)1,068,5271,646,702+578,1755,4922,7010.28%-2,792
IRONWOOD PHARMACEUTICALS INC(IRWD)1,625,0001,641,891+16,89114,15410,7051.12%-3,449
WAVE LIFE SCIENCES LTD(WVE)3,932,0823,975,521+43,43924,26119,8382.08%-4,423
SUTRO BIOPHARMA INC(STRO)2,001,7272,023,683+21,95611,3105,9290.62%-5,380
PROTAGONIST THERAPEUTICS INC1,144,242800,000-344,24233,10327,7202.90%-5,383
BURNING ROCK BIOTECH LTD(BNR)9,640,9140-9,640,9147,0200—-7,020
2SEVENTY BIO INC5,953,8255,953,825031,85322,9222.40%-8,931
VERA THERAPEUTICS INC(VERA)1,526,7871,543,669+16,88265,83555,8505.85%-9,985
SYNDAX PHARMACEUTICALS INC(SNDX)5,660,0005,722,057+62,057134,708117,47412.30%-17,234
LIQUIDIA CORPORATION(LQDA)2,248,324916,574-1,331,75033,16310,9991.15%-22,164
Page 1 of 1